Cargando…

The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic Shock

We herein report the clinical potential of Impella 5.0 support, which is a catheter-mounted micro-axial left ventricular support device, in a 39-year-old man with recurrent fulminant viral myocarditis complicated with profound cardiogenic shock despite inotropic infusion and an intra-aortic balloon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogawa, Shou, Suzuki, Makoto, Ochi, Hiroyuki, Saji, Mike, Mahara, Keitaro, Takamisawa, Itaru, Nishigawa, Kosaku, Furuichi, Yuko, Takanashi, Shuichiro, Isobe, Mitsuaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548930/ https://www.ncbi.nlm.nih.gov/pubmed/30626823 http://dx.doi.org/10.2169/internalmedicine.1866-18

Ejemplares similares

Pulmonary Hemorrhaging Caused by Acute Severe Mitral Regurgitation during Transcatheter Aortic Valve Implantation
por: Higuchi, Ryosuke, et al.
Publicado: (2017)

Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
por: Hori, Takayuki, et al.
Publicado: (2022)

Associations of increased arterial stiffness with left ventricular ejection performance and right ventricular systolic pressure in mitral regurgitation before and after surgery: Wave intensity analysis
por: Niki, Kiyomi, et al.
Publicado: (2017)

Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare Case
por: Fox, Henrik, et al.
Publicado: (2017)

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Acute hypoxemia caused by Impella in a patient with fulminant myocarditis and patent foramen ovale
por: Shibao, Kodai, et al.
Publicado: (2022)

Prevalence, Predictors, and Mid-Term Outcomes of Non-Home Discharge After Transcatheter Aortic Valve Implantation
por: Muto, Yuuki, et al.
Publicado: (2020)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)

Coronary endarterectomy for diffusely diseased coronary artery: An ace in the hole in coronary artery surgery
por: Nishigawa, Kosaku, et al.
Publicado: (2021)

COVID-19 fulminant myocarditis recovered with veno-arterial extracorporeal membrane oxygenation and Impella CP
por: Matsushita, Shunsuke, et al.
Publicado: (2023)

Elasomeran: Acute fulminant lymphocytic myocarditis and cardiogenic shock: case report
Publicado: (2022)

An Undetected Pheochromocytoma Leading to Fulminant Adrenergic Myocarditis Complicated by Cardiogenic Shock
por: Tran, Nam Q, et al.
Publicado: (2023)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Biventricular impella (BiPella) utilization in fulminant COVID-19 myopericarditis-mediated cardiogenic shock during pregnancy
por: Srichawla, Bahadar S., et al.
Publicado: (2023)

Novel Combination of Impella and Extra Corporeal Membrane Oxygenation as a Bridge to Full Recovery in Fulminant Myocarditis
por: Narain, Sachin, et al.
Publicado: (2012)

Prognosis of patients with active cancer undergoing transcatheter aortic valve implantation: An insight from Japanese multicenter registry
por: Kojima, Yoshimasa, et al.
Publicado: (2022)

Fulminant Giant Cell Myocarditis and Cardiogenic Shock: An Unusual Presentation of Malignant Thymoma
por: Koul, Deepak, et al.
Publicado: (2010)

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

Short-term use of “ECMELLA” in the context of fulminant eosinophilic myocarditis with cardiogenic shock
por: Bohné, Mintje, et al.
Publicado: (2020)

Efficacy of central extracorporeal life support for patients with fulminant myocarditis and cardiogenic shock
por: Tadokoro, Naoki, et al.
Publicado: (2021)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

Long‐term outcomes in Japanese nonagenarians undergoing transcatheter aortic valve implantation: A multi‐center analysis
por: Yokoyama, Hiroaki, et al.
Publicado: (2019)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Predictors for all-cause mortality in men after transcatheter aortic valve replacement: A report from the LAPLACE-TAVI registry
por: Nishida, Kota, et al.
Publicado: (2023)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient
por: Ghafoor, Khuzema, et al.
Publicado: (2021)

Unloading using Impella CP during profound cardiogenic shock caused by left ventricular failure in a large animal model: impact on the right ventricle
por: Josiassen, Jakob, et al.
Publicado: (2020)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Combination Immunosuppressive Therapy for Giant Cell Myocarditis
por: Funaki, Takashi, et al.
Publicado: (2022)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection presented with cardiogenic shock in a young patient
por: Avşar, Şahin, et al.
Publicado: (2019)

Fulminant Influenza A myocarditis in a patient presenting with cardiogenic shock and biventricular thrombi: a case report
por: Cottet, Mylène, et al.
Publicado: (2022)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ppr19t0ogc80sv902nrjmqltga